Thank you, Mr. Chair.
Madam Beauchemin, if I understood your testimony correctly, you acknowledge that the pharmaceutical industry provides rebates to provinces. We heard testimony from the PMPRB officials a few weeks ago that part of the changes will require transparency, so that they have a better understanding of what the real prices are in the marketplace to help them set effective pricing for Canadians.
Do you oppose that requirement to have pharmaceutical companies transparently reveal the rebates that they're giving?